Concorde Asset Management, LLC - PROTAGENIC THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

PROTAGENIC THERAPEUTICS INC's ticker is PTIX and the CUSIP is 74365N103. A total of 18 filers reported holding PROTAGENIC THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Concorde Asset Management, LLC ownership history of PROTAGENIC THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$6,687
-33.1%
16,7180.0%0.01%
-45.5%
Q3 2022$10,000
+11.1%
16,718
+34.6%
0.01%
-21.4%
Q2 2022$9,000–12,418–0.01%–
 Download
Other shareholders
PROTAGENIC THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
FNY Investment Advisers, LLC 75,000$310.04%
Concorde Asset Management, LLC 16,718$6,6870.01%
Virtu Financial LLC 10,110$40.00%
Warberg Asset Management LLC 20,000$8,0000.00%
CWM, LLC 3$00.00%
VANGUARD GROUP INC 236,309$94,5230.00%
UBS Group AG 17,153$6,8610.00%
OSAIC HOLDINGS, INC. 11,055$4,0000.00%
BANK OF AMERICA CORP /DE/ 4$20.00%
WELLS FARGO & COMPANY/MN 90$360.00%
View complete list of PROTAGENIC THERAPEUTICS INC shareholders